Non-alcoholic fatty liver disease in pregnancy is associated with adverse maternal and perinatal outcomes
The prevalence of non-alcoholic fatty liver disease (NAFLD) is rising in young adults, with potential implications for reproductive-aged women. Whether NAFLD during pregnancy confers more serious risks for maternal or perinatal health is unclear. Using weighted discharge data from the US national in...
Gespeichert in:
| Veröffentlicht in: | Journal of hepatology 2020-09, Vol.73 (3), p.516-522 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 522 |
|---|---|
| container_issue | 3 |
| container_start_page | 516 |
| container_title | Journal of hepatology |
| container_volume | 73 |
| creator | Sarkar, Monika Grab, Joshua Dodge, Jennifer L. Gunderson, Erica P. Rubin, Jessica Irani, Roxanna A. Cedars, Marcelle Terrault, Norah |
| description | The prevalence of non-alcoholic fatty liver disease (NAFLD) is rising in young adults, with potential implications for reproductive-aged women. Whether NAFLD during pregnancy confers more serious risks for maternal or perinatal health is unclear.
Using weighted discharge data from the US national inpatient sample, we evaluated temporal trends of NAFLD in pregnancies after 20 weeks gestation, and compared outcomes to pregnancies with other chronic liver diseases (CLDs) or no CLD. Study outcomes included preterm birth, postpartum hemorrhage, hypertensive complications (pre-eclampsia, eclampsia, and/or hemolysis, elevated liver enzymes, and low platelets syndrome), and maternal or fetal death. NAFLD prevalence was estimated by calendar year and temporal trends tested by linear regression. Outcomes were analyzed by logistic regression adjusted for age, race, multiple gestation, and pre-pregnancy diabetes, obesity, dyslipidemia and hypertension.
Among 18,574,225 pregnancies, 5,640 had NAFLD and 115,210 had other, non-NAFLD CLD. Pregnancies with NAFLD nearly tripled from 10.5/100,000 pregnancies in 2007 to 28.9/100,000 in 2015 (p |
| doi_str_mv | 10.1016/j.jhep.2020.03.049 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7438303</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0168827820302154</els_id><sourcerecordid>2412993562</sourcerecordid><originalsourceid>FETCH-LOGICAL-c455t-d63f846276c030b9fc855d33e0001720ecd77653ea59b2a0b13f9cf3d16a78a23</originalsourceid><addsrcrecordid>eNp9kU2LFDEQhoMo7rj6BzxIjl66zUcn3Q0iyOIXLHrRc6hJqncydCdtkhmZf2-GWRe9eAqVeuqtl3oJeclZyxnXb_btfodrK5hgLZMt68ZHZMM1Yw3THX9MNhUamkH0wxV5lvOeMSbZ2D0lV1IoyTuuNsR_jaGB2cZdnL2lE5RyorM_YqLOZ4SM1Ae6JrwLEOyJ-kwh52g9FHT0ly87Cq7SlVvqVwowUwiOrph8gFKreCg2LpifkycTzBlf3L_X5MfHD99vPje33z59uXl_29hOqdI4Laeh06LXtrrdjpMdlHJSYnXPe8HQur7XSiKocSuAbbmcRjtJxzX0Awh5Td5ddNfDdkFnMZQEs1mTXyCdTARv_u0EvzN38Wj6Tg6SySrw-l4gxZ8HzMUsPlucZwgYD9mIjotxlEqfd4kLalPMOeH0sIYzc87I7M05I3POyDBpakZ16NXfBh9G_oRSgbcXAOuZjh6TydZjsOh8QluMi_5_-r8BihylUQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2412993562</pqid></control><display><type>article</type><title>Non-alcoholic fatty liver disease in pregnancy is associated with adverse maternal and perinatal outcomes</title><source>ScienceDirect Journals (5 years ago - present)</source><creator>Sarkar, Monika ; Grab, Joshua ; Dodge, Jennifer L. ; Gunderson, Erica P. ; Rubin, Jessica ; Irani, Roxanna A. ; Cedars, Marcelle ; Terrault, Norah</creator><creatorcontrib>Sarkar, Monika ; Grab, Joshua ; Dodge, Jennifer L. ; Gunderson, Erica P. ; Rubin, Jessica ; Irani, Roxanna A. ; Cedars, Marcelle ; Terrault, Norah</creatorcontrib><description>The prevalence of non-alcoholic fatty liver disease (NAFLD) is rising in young adults, with potential implications for reproductive-aged women. Whether NAFLD during pregnancy confers more serious risks for maternal or perinatal health is unclear.
Using weighted discharge data from the US national inpatient sample, we evaluated temporal trends of NAFLD in pregnancies after 20 weeks gestation, and compared outcomes to pregnancies with other chronic liver diseases (CLDs) or no CLD. Study outcomes included preterm birth, postpartum hemorrhage, hypertensive complications (pre-eclampsia, eclampsia, and/or hemolysis, elevated liver enzymes, and low platelets syndrome), and maternal or fetal death. NAFLD prevalence was estimated by calendar year and temporal trends tested by linear regression. Outcomes were analyzed by logistic regression adjusted for age, race, multiple gestation, and pre-pregnancy diabetes, obesity, dyslipidemia and hypertension.
Among 18,574,225 pregnancies, 5,640 had NAFLD and 115,210 had other, non-NAFLD CLD. Pregnancies with NAFLD nearly tripled from 10.5/100,000 pregnancies in 2007 to 28.9/100,000 in 2015 (p <0.001). Compared to the other groups, patients with NAFLD during pregnancy more frequently experienced gestational diabetes (7–8% vs. 23%), hypertensive complications (4% vs. 16%), postpartum hemorrhage (3–5% vs. 6%), and preterm birth (5–7% vs. 9%), all p values ≤0.01. On adjusted analysis, compared to no CLD, NAFLD was associated with hypertensive complications, preterm birth, postpartum hemorrhage and possibly maternal (but not fetal) death.
The prevalence of NAFLD in pregnancy has nearly tripled in the last decade and is independently associated with hypertensive complications, postpartum hemorrhage and preterm birth. NAFLD should be considered a high-risk obstetric condition, with clinical implications for pre-conception counseling and pregnancy care.
The prevalence of non-alcoholic fatty liver disease (NAFLD) in pregnancy has almost tripled over the past 10 years. Having NAFLD during pregnancy increases risks for both the mother and the baby, including hypertensive complications of pregnancy, bleeding after delivery, and preterm birth. Thus, pre-conception counseling is warranted with consideration of high-risk obstetric management among women with NAFLD in pregnancy.
[Display omitted]
•The prevalence of non-alcoholic fatty liver disease (NAFLD) has nearly tripled over the past decade.•Maternal and perinatal complications are more common in mothers with NAFLD than in those with other liver diseases.•NAFLD in pregnancy is independently associated with adverse maternal and perinatal outcomes.•Women with NAFLD warrant pre-conception counseling, and may benefit from high-risk obstetrics management during pregnancy.</description><identifier>ISSN: 0168-8278</identifier><identifier>EISSN: 1600-0641</identifier><identifier>DOI: 10.1016/j.jhep.2020.03.049</identifier><identifier>PMID: 32531415</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Chronic liver disease ; Complications ; Non-alcoholic steatohepatitis ; Reproductive health</subject><ispartof>Journal of hepatology, 2020-09, Vol.73 (3), p.516-522</ispartof><rights>2020 European Association for the Study of the Liver</rights><rights>Copyright © 2020 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c455t-d63f846276c030b9fc855d33e0001720ecd77653ea59b2a0b13f9cf3d16a78a23</citedby><cites>FETCH-LOGICAL-c455t-d63f846276c030b9fc855d33e0001720ecd77653ea59b2a0b13f9cf3d16a78a23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jhep.2020.03.049$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32531415$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sarkar, Monika</creatorcontrib><creatorcontrib>Grab, Joshua</creatorcontrib><creatorcontrib>Dodge, Jennifer L.</creatorcontrib><creatorcontrib>Gunderson, Erica P.</creatorcontrib><creatorcontrib>Rubin, Jessica</creatorcontrib><creatorcontrib>Irani, Roxanna A.</creatorcontrib><creatorcontrib>Cedars, Marcelle</creatorcontrib><creatorcontrib>Terrault, Norah</creatorcontrib><title>Non-alcoholic fatty liver disease in pregnancy is associated with adverse maternal and perinatal outcomes</title><title>Journal of hepatology</title><addtitle>J Hepatol</addtitle><description>The prevalence of non-alcoholic fatty liver disease (NAFLD) is rising in young adults, with potential implications for reproductive-aged women. Whether NAFLD during pregnancy confers more serious risks for maternal or perinatal health is unclear.
Using weighted discharge data from the US national inpatient sample, we evaluated temporal trends of NAFLD in pregnancies after 20 weeks gestation, and compared outcomes to pregnancies with other chronic liver diseases (CLDs) or no CLD. Study outcomes included preterm birth, postpartum hemorrhage, hypertensive complications (pre-eclampsia, eclampsia, and/or hemolysis, elevated liver enzymes, and low platelets syndrome), and maternal or fetal death. NAFLD prevalence was estimated by calendar year and temporal trends tested by linear regression. Outcomes were analyzed by logistic regression adjusted for age, race, multiple gestation, and pre-pregnancy diabetes, obesity, dyslipidemia and hypertension.
Among 18,574,225 pregnancies, 5,640 had NAFLD and 115,210 had other, non-NAFLD CLD. Pregnancies with NAFLD nearly tripled from 10.5/100,000 pregnancies in 2007 to 28.9/100,000 in 2015 (p <0.001). Compared to the other groups, patients with NAFLD during pregnancy more frequently experienced gestational diabetes (7–8% vs. 23%), hypertensive complications (4% vs. 16%), postpartum hemorrhage (3–5% vs. 6%), and preterm birth (5–7% vs. 9%), all p values ≤0.01. On adjusted analysis, compared to no CLD, NAFLD was associated with hypertensive complications, preterm birth, postpartum hemorrhage and possibly maternal (but not fetal) death.
The prevalence of NAFLD in pregnancy has nearly tripled in the last decade and is independently associated with hypertensive complications, postpartum hemorrhage and preterm birth. NAFLD should be considered a high-risk obstetric condition, with clinical implications for pre-conception counseling and pregnancy care.
The prevalence of non-alcoholic fatty liver disease (NAFLD) in pregnancy has almost tripled over the past 10 years. Having NAFLD during pregnancy increases risks for both the mother and the baby, including hypertensive complications of pregnancy, bleeding after delivery, and preterm birth. Thus, pre-conception counseling is warranted with consideration of high-risk obstetric management among women with NAFLD in pregnancy.
[Display omitted]
•The prevalence of non-alcoholic fatty liver disease (NAFLD) has nearly tripled over the past decade.•Maternal and perinatal complications are more common in mothers with NAFLD than in those with other liver diseases.•NAFLD in pregnancy is independently associated with adverse maternal and perinatal outcomes.•Women with NAFLD warrant pre-conception counseling, and may benefit from high-risk obstetrics management during pregnancy.</description><subject>Chronic liver disease</subject><subject>Complications</subject><subject>Non-alcoholic steatohepatitis</subject><subject>Reproductive health</subject><issn>0168-8278</issn><issn>1600-0641</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kU2LFDEQhoMo7rj6BzxIjl66zUcn3Q0iyOIXLHrRc6hJqncydCdtkhmZf2-GWRe9eAqVeuqtl3oJeclZyxnXb_btfodrK5hgLZMt68ZHZMM1Yw3THX9MNhUamkH0wxV5lvOeMSbZ2D0lV1IoyTuuNsR_jaGB2cZdnL2lE5RyorM_YqLOZ4SM1Ae6JrwLEOyJ-kwh52g9FHT0ly87Cq7SlVvqVwowUwiOrph8gFKreCg2LpifkycTzBlf3L_X5MfHD99vPje33z59uXl_29hOqdI4Laeh06LXtrrdjpMdlHJSYnXPe8HQur7XSiKocSuAbbmcRjtJxzX0Awh5Td5ddNfDdkFnMZQEs1mTXyCdTARv_u0EvzN38Wj6Tg6SySrw-l4gxZ8HzMUsPlucZwgYD9mIjotxlEqfd4kLalPMOeH0sIYzc87I7M05I3POyDBpakZ16NXfBh9G_oRSgbcXAOuZjh6TydZjsOh8QluMi_5_-r8BihylUQ</recordid><startdate>20200901</startdate><enddate>20200901</enddate><creator>Sarkar, Monika</creator><creator>Grab, Joshua</creator><creator>Dodge, Jennifer L.</creator><creator>Gunderson, Erica P.</creator><creator>Rubin, Jessica</creator><creator>Irani, Roxanna A.</creator><creator>Cedars, Marcelle</creator><creator>Terrault, Norah</creator><general>Elsevier B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20200901</creationdate><title>Non-alcoholic fatty liver disease in pregnancy is associated with adverse maternal and perinatal outcomes</title><author>Sarkar, Monika ; Grab, Joshua ; Dodge, Jennifer L. ; Gunderson, Erica P. ; Rubin, Jessica ; Irani, Roxanna A. ; Cedars, Marcelle ; Terrault, Norah</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c455t-d63f846276c030b9fc855d33e0001720ecd77653ea59b2a0b13f9cf3d16a78a23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Chronic liver disease</topic><topic>Complications</topic><topic>Non-alcoholic steatohepatitis</topic><topic>Reproductive health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sarkar, Monika</creatorcontrib><creatorcontrib>Grab, Joshua</creatorcontrib><creatorcontrib>Dodge, Jennifer L.</creatorcontrib><creatorcontrib>Gunderson, Erica P.</creatorcontrib><creatorcontrib>Rubin, Jessica</creatorcontrib><creatorcontrib>Irani, Roxanna A.</creatorcontrib><creatorcontrib>Cedars, Marcelle</creatorcontrib><creatorcontrib>Terrault, Norah</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of hepatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sarkar, Monika</au><au>Grab, Joshua</au><au>Dodge, Jennifer L.</au><au>Gunderson, Erica P.</au><au>Rubin, Jessica</au><au>Irani, Roxanna A.</au><au>Cedars, Marcelle</au><au>Terrault, Norah</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Non-alcoholic fatty liver disease in pregnancy is associated with adverse maternal and perinatal outcomes</atitle><jtitle>Journal of hepatology</jtitle><addtitle>J Hepatol</addtitle><date>2020-09-01</date><risdate>2020</risdate><volume>73</volume><issue>3</issue><spage>516</spage><epage>522</epage><pages>516-522</pages><issn>0168-8278</issn><eissn>1600-0641</eissn><abstract>The prevalence of non-alcoholic fatty liver disease (NAFLD) is rising in young adults, with potential implications for reproductive-aged women. Whether NAFLD during pregnancy confers more serious risks for maternal or perinatal health is unclear.
Using weighted discharge data from the US national inpatient sample, we evaluated temporal trends of NAFLD in pregnancies after 20 weeks gestation, and compared outcomes to pregnancies with other chronic liver diseases (CLDs) or no CLD. Study outcomes included preterm birth, postpartum hemorrhage, hypertensive complications (pre-eclampsia, eclampsia, and/or hemolysis, elevated liver enzymes, and low platelets syndrome), and maternal or fetal death. NAFLD prevalence was estimated by calendar year and temporal trends tested by linear regression. Outcomes were analyzed by logistic regression adjusted for age, race, multiple gestation, and pre-pregnancy diabetes, obesity, dyslipidemia and hypertension.
Among 18,574,225 pregnancies, 5,640 had NAFLD and 115,210 had other, non-NAFLD CLD. Pregnancies with NAFLD nearly tripled from 10.5/100,000 pregnancies in 2007 to 28.9/100,000 in 2015 (p <0.001). Compared to the other groups, patients with NAFLD during pregnancy more frequently experienced gestational diabetes (7–8% vs. 23%), hypertensive complications (4% vs. 16%), postpartum hemorrhage (3–5% vs. 6%), and preterm birth (5–7% vs. 9%), all p values ≤0.01. On adjusted analysis, compared to no CLD, NAFLD was associated with hypertensive complications, preterm birth, postpartum hemorrhage and possibly maternal (but not fetal) death.
The prevalence of NAFLD in pregnancy has nearly tripled in the last decade and is independently associated with hypertensive complications, postpartum hemorrhage and preterm birth. NAFLD should be considered a high-risk obstetric condition, with clinical implications for pre-conception counseling and pregnancy care.
The prevalence of non-alcoholic fatty liver disease (NAFLD) in pregnancy has almost tripled over the past 10 years. Having NAFLD during pregnancy increases risks for both the mother and the baby, including hypertensive complications of pregnancy, bleeding after delivery, and preterm birth. Thus, pre-conception counseling is warranted with consideration of high-risk obstetric management among women with NAFLD in pregnancy.
[Display omitted]
•The prevalence of non-alcoholic fatty liver disease (NAFLD) has nearly tripled over the past decade.•Maternal and perinatal complications are more common in mothers with NAFLD than in those with other liver diseases.•NAFLD in pregnancy is independently associated with adverse maternal and perinatal outcomes.•Women with NAFLD warrant pre-conception counseling, and may benefit from high-risk obstetrics management during pregnancy.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>32531415</pmid><doi>10.1016/j.jhep.2020.03.049</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0168-8278 |
| ispartof | Journal of hepatology, 2020-09, Vol.73 (3), p.516-522 |
| issn | 0168-8278 1600-0641 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7438303 |
| source | ScienceDirect Journals (5 years ago - present) |
| subjects | Chronic liver disease Complications Non-alcoholic steatohepatitis Reproductive health |
| title | Non-alcoholic fatty liver disease in pregnancy is associated with adverse maternal and perinatal outcomes |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T15%3A50%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Non-alcoholic%20fatty%20liver%20disease%20in%20pregnancy%20is%20associated%20with%20adverse%20maternal%20and%20perinatal%20outcomes&rft.jtitle=Journal%20of%20hepatology&rft.au=Sarkar,%20Monika&rft.date=2020-09-01&rft.volume=73&rft.issue=3&rft.spage=516&rft.epage=522&rft.pages=516-522&rft.issn=0168-8278&rft.eissn=1600-0641&rft_id=info:doi/10.1016/j.jhep.2020.03.049&rft_dat=%3Cproquest_pubme%3E2412993562%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2412993562&rft_id=info:pmid/32531415&rft_els_id=S0168827820302154&rfr_iscdi=true |